Indication
AIDS-related Kaposi Sarcoma
2 clinical trials
2 products
1 drug
Clinical trial
A Randomized, Multi-center, Cross-over, Comparative Bioavailability Study of DOXIL/CAELYX Manufactured at a New Site in Patients With Advanced or Refractory Ovarian or Breast CancerStatus: Not yet recruiting, Estimated PCD: 2024-04-01
Product
DOXIL/CAELYXClinical trial
A Phase III, Randomized, Open-Label, Non-Inferiority Study of Paclitaxel and Pegylated Liposomal Doxorubicin for Treatment of HIV-related Kaposi Sarcoma in Resource-Limited SettingsStatus: Not yet recruiting, Estimated PCD: 2027-12-01
Drug
Tiragolumab